$415 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 69 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 27.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences Inc | $28,122,000 | +1.4% | 402,784 | 0.0% | 6.78% | -7.3% | |
| NBIX | Buy | Neurocrine Biosciences Inc | $27,740,000 | +37.8% | 289,500 | +39.9% | 6.69% | +25.9% |
| HZNP | HORIZON THERAPEUTICS PUB LTD | $26,042,000 | +16.9% | 237,873 | 0.0% | 6.28% | +6.8% | |
| AMGN | Buy | Amgen Inc | $25,146,000 | +102.3% | 118,300 | +132.0% | 6.06% | +84.8% |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $24,490,000 | +43.1% | 176,400 | 0.0% | 5.91% | +30.7% | |
| SGEN | Sell | SEAGEN INC | $18,618,000 | -18.6% | 109,700 | -24.3% | 4.49% | -25.6% |
| INCY | Buy | Incyte Corp | $18,590,000 | +61.5% | 270,360 | +97.5% | 4.48% | +47.6% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $17,419,000 | +538.1% | 98,500 | +482.8% | 4.20% | +482.7% |
| PTCT | PTC Therapuetics COM | $16,712,000 | -11.8% | 449,000 | 0.0% | 4.03% | -19.4% | |
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $14,160,000 | -43.9% | 75,000 | -49.7% | 3.42% | -48.7% |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $14,007,000 | +7.2% | 77,222 | +19.1% | 3.38% | -2.1% |
| ILMN | New | ILLUMINA INC | $10,944,000 | – | 27,000 | +100.0% | 2.64% | – |
| EXEL | Buy | Exelixis Inc | $10,344,000 | +459.1% | 489,534 | +382.1% | 2.50% | +411.3% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $9,286,000 | +62.0% | 103,100 | +71.5% | 2.24% | +48.1% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $9,217,000 | -2.8% | 138,741 | +14.2% | 2.22% | -11.2% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $9,215,000 | +3055.8% | 380,000 | +1800.0% | 2.22% | +2787.0% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $9,020,000 | +92.5% | 236,000 | +42.2% | 2.18% | +75.9% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $7,934,000 | +27.3% | 297,500 | +47.0% | 1.91% | +16.3% |
| BIIB | Sell | Biogen Inc | $7,212,000 | -57.1% | 25,500 | -47.4% | 1.74% | -60.8% |
| CCXI | Buy | CRISPR THERAPEUTICS AGnamen akt | $7,131,000 | +76.4% | 94,300 | +62.3% | 1.72% | +61.2% |
| KALV | Buy | Kalvista Pharmaceuticals Inc | $6,687,000 | -1.5% | 383,233 | +35.3% | 1.61% | -10.0% |
| INSM | Buy | INSMED INC | $6,637,000 | +133.0% | 241,100 | +140.9% | 1.60% | +112.9% |
| QURE | Sell | UNIQURE NV | $5,834,000 | -39.9% | 182,194 | -42.3% | 1.41% | -45.1% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $5,755,000 | +62.0% | 44,200 | +121.0% | 1.39% | +48.0% |
| ASND | Buy | Ascendis Pharma ASsponsored adr | $4,686,000 | +158.2% | 29,400 | +113.0% | 1.13% | +135.9% |
| REGN | Sell | Regeneron Pharmaceuticals | $4,656,000 | -77.6% | 7,700 | -79.3% | 1.12% | -79.5% |
| GH | Buy | GUARDANT HEALTH INC | $4,563,000 | +116.1% | 36,500 | +114.7% | 1.10% | +97.3% |
| BMRN | Biomarin Pharmaceutical Inc | $4,263,000 | -7.4% | 55,156 | 0.0% | 1.03% | -15.4% | |
| ZLAB | Buy | ZAI LAB LTDadr | $4,098,000 | +81.0% | 38,958 | +204.4% | 0.99% | +65.2% |
| DYN | Buy | DYNE THERAPEUTICS INC | $4,060,000 | +43.0% | 250,000 | +85.2% | 0.98% | +30.5% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $2,992,000 | +24.0% | 235,000 | +37.6% | 0.72% | +13.3% |
| ITCI | INTRA CELLULAR THERAPIES INC | $2,957,000 | -8.8% | 79,456 | 0.0% | 0.71% | -16.7% | |
| IDYA | New | IDEAYA BIOSCIENCES INC | $2,778,000 | – | 109,000 | +100.0% | 0.67% | – |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $2,724,000 | -29.6% | 123,500 | -58.6% | 0.66% | -35.7% |
| STRO | SUTRO BIOPHARMA INC | $2,629,000 | +1.5% | 139,331 | 0.0% | 0.63% | -7.3% | |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $2,497,000 | – | 49,500 | +100.0% | 0.60% | – |
| HCM | HUTCHMED CHINA LTDsponsored ads | $2,484,000 | -7.0% | 68,000 | 0.0% | 0.60% | -15.0% | |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $2,263,000 | +51.1% | 40,000 | +17.5% | 0.55% | +38.2% |
| ZGNX | New | ZOGENIX INC | $2,051,000 | – | 135,000 | +100.0% | 0.50% | – |
| BPMC | Blueprint Medicines Corp | $2,003,000 | +16.8% | 19,500 | 0.0% | 0.48% | +6.6% | |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $1,883,000 | – | 63,000 | +100.0% | 0.45% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $1,696,000 | – | 215,000 | +100.0% | 0.41% | – |
| ALLK | ALLAKOS INC | $1,662,000 | +24.2% | 15,700 | 0.0% | 0.40% | +13.6% | |
| FATE | New | FATE THERAPEUTICS INC | $1,660,000 | – | 28,000 | +100.0% | 0.40% | – |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $1,582,000 | – | 25,000 | +100.0% | 0.38% | – |
| NKTX | Sell | NKARTA INC | $1,570,000 | -29.1% | 56,445 | -19.4% | 0.38% | -35.2% |
| KOD | New | KODIAK SCIENCES INC | $1,553,000 | – | 16,200 | +100.0% | 0.38% | – |
| IONS | Sell | Ionis Pharmaceuticals Inc | $1,502,000 | -79.3% | 44,781 | -75.4% | 0.36% | -81.1% |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $1,430,000 | -5.2% | 58,000 | 0.0% | 0.34% | -13.3% | |
| IMAB | Buy | I MABsponsored ads | $1,301,000 | +158.6% | 18,000 | +200.0% | 0.31% | +136.1% |
| ARNA | Arena Pharmaceuticals Inc | $1,250,000 | -12.6% | 21,000 | 0.0% | 0.30% | -20.4% | |
| NKTR | NEKTAR THERAPEUTICS | $1,201,000 | +4.5% | 67,000 | 0.0% | 0.29% | -4.3% | |
| ORIC | ORIC PHARMACEUTICALS INC | $1,104,000 | +17.7% | 53,000 | 0.0% | 0.27% | +7.3% | |
| EXAS | Exact Sciences Corp | $1,021,000 | -23.1% | 10,700 | 0.0% | 0.25% | -29.9% | |
| AGIO | Agios Pharmaceuticals Inc | $992,000 | -16.3% | 21,500 | 0.0% | 0.24% | -23.6% | |
| FOLD | Amicus Therapeutics Inc | $904,000 | -0.9% | 94,600 | 0.0% | 0.22% | -9.5% | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS INC | $564,000 | -84.6% | 16,600 | -83.4% | 0.14% | -85.9% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $555,000 | -27.3% | 21,800 | 0.0% | 0.13% | -33.3% | |
| IMVT | IMMUNOVANT INC | $521,000 | -17.8% | 60,000 | 0.0% | 0.13% | -24.6% | |
| AXSM | AXSOME THERAPEUTICS INC | $461,000 | -51.2% | 14,000 | 0.0% | 0.11% | -55.4% | |
| GMDA | GAMIDA CELL LTD | $418,000 | -38.7% | 107,000 | 0.0% | 0.10% | -43.9% | |
| XENE | XENON PHARMACEUTICALS INC | $388,000 | -18.1% | 25,500 | 0.0% | 0.09% | -24.8% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $371,000 | -30.7% | 44,000 | 0.0% | 0.09% | -36.9% | |
| ANAB | ANAPTYSBIO INC | $271,000 | +4.6% | 10,000 | 0.0% | 0.06% | -4.4% | |
| RLMD | New | RELMADA THERAPEUTICS INC | $261,000 | – | 10,000 | +100.0% | 0.06% | – |
| BLUE | Bluebird Bio Inc | $210,000 | -40.2% | 11,000 | 0.0% | 0.05% | -45.2% | |
| FGEN | FibroGen Inc | $201,000 | -61.7% | 19,700 | 0.0% | 0.05% | -65.5% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $114,000 | -43.3% | 9,500 | 0.0% | 0.03% | -49.1% | |
| ARDX | Exit | ARDELYX INC | $0 | – | -78,000 | -100.0% | -0.16% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -45,000 | -100.0% | -0.29% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCcm | $0 | – | -23,400 | -100.0% | -0.39% | – |
| SRPT | Exit | Sarepta Therapeutics Inc | $0 | – | -31,500 | -100.0% | -0.65% | – |
| HALO | Exit | Halozyme Therapeutics Inc | $0 | – | -82,633 | -100.0% | -0.99% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -152,000 | -100.0% | -1.80% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -60,500 | -100.0% | -2.00% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -43,300 | -100.0% | -2.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.